13F HOLDINGS REPORT
Velan Capital Investment Management LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001848809-24-000011
Total Value
$106.9M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | JASPER THERAPEUTICS INC | JSPRW | 1,188,500 | $22.4M | 20.91% |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 350,666 | $20.2M | 18.87% |
| 3 | SPDR SER TR | 78464A870 | 150,000 | $14.8M | 13.86% |
| 4 | HERON THERAPEUTICS INC | HRTX | 6,986,744 | $13.9M | 13.00% |
| 5 | TOURMALINE BIO INC | 89157D105 | 319,080 | $8.2M | 7.67% |
| 6 | JASPER THERAPEUTICS INC | JSPRW | 245,328 | $4.6M | 4.32% |
| 7 | REZOLUTE INC | RZLT | 800,000 | $3.9M | 3.63% |
| 8 | LIQUIDIA CORPORATION | LQDA | 300,000 | $3.0M | 2.81% |
| 9 | CONTEXT THERAPEUTICS INC | CNTX | 1,290,323 | $2.5M | 2.36% |
| 10 | INSPIREMD INC | NSPR | 904,029 | $2.4M | 2.27% |
| 11 | SCPHARMACEUTICALS INC | 810648105 | 517,668 | $2.4M | 2.21% |
| 12 | TELA BIO INC | TELA | 747,410 | $1.9M | 1.77% |
| 13 | OPTINOSE INC | 68404V100 | 2,146,608 | $1.4M | 1.34% |
| 14 | ZEVRA THERAPEUTICS INC | ZVRA | 200,000 | $1.4M | 1.30% |
| 15 | PROTARA THERAPEUTICS INC | TARA | 574,000 | $1.1M | 0.98% |
| 16 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 50,000 | $1.0M | 0.96% |
| 17 | SKYE BIOSCIENCE INC | SKYE | 211,071 | $825,288 | 0.77% |
| 18 | KIORA PHARMACEUTICALS INC | KPHMW | 122,223 | $447,336 | 0.42% |
| 19 | TOURMALINE BIO INC | 89157D105 | 12,110 | $311,348 | 0.29% |
| 20 | TENAX THERAPEUTICS INC | TENX | 83,333 | $288,332 | 0.27% |